Cargando…

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination

BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jha, Manish K, Minhajuddin, Abu, Gadad, Bharathi S, Trivedi, Madhukar H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737519/ https://www.ncbi.nlm.nih.gov/pubmed/29016822 http://dx.doi.org/10.1093/ijnp/pyx060

Ejemplares similares

Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
por: Jha, Manish K., et al.
Publicado: (2019)

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
por: Jha, Manish K, et al.
Publicado: (2019)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
por: Minhajuddin, Abu, et al.
Publicado: (2020)

Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022)

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli
por: Ou, Jin, et al.
Publicado: (2022)

Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment
por: Liao, Huijuan, et al.
Publicado: (2023)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
por: Jordan, Sue, et al.
Publicado: (2016)

Identification of SSRI-evoked antidepressant sensory signals by decoding vagus nerve activity
por: West, Christine L., et al.
Publicado: (2021)

Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice
por: Poleszak, Ewa, et al.
Publicado: (2020)

Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice
por: Stasiuk, Weronika, et al.
Publicado: (2016)

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments
por: Gupta, Ramesh K, et al.
Publicado: (2006)

Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants
por: Herzallah, Mohammad M., et al.
Publicado: (2013)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
por: Ben-Sheetrit, Joseph, et al.
Publicado: (2023)

Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder
por: Young, Kymberly D., et al.
Publicado: (2020)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
por: Sneep, S., et al.
Publicado: (2022)

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
por: Wong, Win Lee Edwin, et al.
Publicado: (2023)

Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2023)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Higher parental education was associated with better asthma control
por: Strömberg Celind, Frida, et al.
Publicado: (2018)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

Can targeted metabolomics predict depression recovery? Results from the CO-MED trial
por: Czysz, Andrew H., et al.
Publicado: (2019)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography
por: Agacayak, Kamil Serkan, et al.
Publicado: (2019)

Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons
por: Sargin, Derya, et al.
Publicado: (2019)

Bupropion Administration Increases Resting-State Functional Connectivity in Dorso-Medial Prefrontal Cortex
por: Rzepa, Ewelina, et al.
Publicado: (2017)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study
por: Chin Fatt, Cherise R., et al.
Publicado: (2023)

Is the most really the best: a review for the most selective SSRI concept three decades later
por: Allam, M. A.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u82d60osd1fj4a38496mn9uu9g